Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/13393
Type
ArticleCopyright
Open access
Collections
- IOC - Artigos de Periódicos [12973]
Metadata
Show full item record
GENETIC DIVERSITY AND MOLECULAR EPIDEMIOLOGY OF MULTIDRUG-RESISTANT MYCOBACTERIUM TUBERCULOSIS IN MINAS GERAIS STATE, BRAZIL
Minas Gerais
Mycobacterium tuberculosis
Resistência a medicamentos
Variação genética
Molecular epidemiology
Spoligotyping
MIRU-VNTR
IS6110-RFLP
Minas Gerais, Brazil
Genetic diversity
Author
Affilliation
Universidade Federal de Minas Gerais. Faculdade de Medicina. Programa de Pós-Graduação em Doenças Infecciosas e Medicina Tropical. Belo Horizonte, MG, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Biologia Molecular aplicada à Micobactérias. Rio de Janeiro, RJ, Brasil.
Universidade Federal de Minas Gerais. Faculdade de Farmácia. Departamento de Farmácia Social. Laboratório de Biologia Molecular e Saúde Pública. Belo Horizonte, MG, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Biologia Molecular aplicada à Micobactérias. Rio de Janeiro, RJ, Brasil.
Universidade Federal de Minas Gerais. Faculdade de Medicina. Programa de Pós-Graduação em Doenças Infecciosas e Medicina Tropical. Belo Horizonte, MG, Brasil.
Universidade Federal de Minas Gerais. Faculdade de Farmácia. Departamento de Farmácia Social. Laboratório de Biologia Molecular e Saúde Pública. Belo Horizonte, MG, Brasil.
Fundação Ezequiel Dias. Belo Horizonte, MG, Brasil.
Institut for Integrative Cell Biology. Orsay France / Centre Muraz, Bobo-Dioulasso, Burkina Faso.
Institut for Integrative Cell Biology. Orsay France.
Institut for Integrative Cell Biology. Orsay France.
Universidade Federal de Minas Gerais. Faculdade de Medicina. Programa de Pós-Graduação em Doenças Infecciosas e Medicina Tropical. Belo Horizonte, MG, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Biologia Molecular aplicada à Micobactérias. Rio de Janeiro, RJ, Brasil.
Universidade Federal de Minas Gerais. Faculdade de Farmácia. Departamento de Farmácia Social. Laboratório de Biologia Molecular e Saúde Pública. Belo Horizonte, MG, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Biologia Molecular aplicada à Micobactérias. Rio de Janeiro, RJ, Brasil.
Universidade Federal de Minas Gerais. Faculdade de Medicina. Programa de Pós-Graduação em Doenças Infecciosas e Medicina Tropical. Belo Horizonte, MG, Brasil.
Universidade Federal de Minas Gerais. Faculdade de Farmácia. Departamento de Farmácia Social. Laboratório de Biologia Molecular e Saúde Pública. Belo Horizonte, MG, Brasil.
Fundação Ezequiel Dias. Belo Horizonte, MG, Brasil.
Institut for Integrative Cell Biology. Orsay France / Centre Muraz, Bobo-Dioulasso, Burkina Faso.
Institut for Integrative Cell Biology. Orsay France.
Institut for Integrative Cell Biology. Orsay France.
Universidade Federal de Minas Gerais. Faculdade de Medicina. Programa de Pós-Graduação em Doenças Infecciosas e Medicina Tropical. Belo Horizonte, MG, Brasil.
Abstract
BACKGROUND:
We aimed to characterize the genetic diversity of drug-resistant Mycobacterium tuberculosis (MTb) clinical isolates and investigate the molecular epidemiology of multidrug-resistant (MDR) tuberculosis from Minas Gerais State, Brazil.
METHODS:
One hundred and four MTb clinical isolates were assessed by IS6110-RFLP, 24-locus mycobacterial interspersed repetitive units variable-number tandem repeats (MIRU-VNTR), TB-SPRINT (simultaneous spoligotyping and rifampicin-isoniazid drug-resistance mutation analysis) and 3R-SNP-typing (analysis of single-nucleotide polymorphisms in the genes involved in replication, recombination and repair functions).
RESULTS:
Fifty-seven different IS6110-RFLP patterns were found, among which 50 had unique patterns and 17 were grouped into seven clusters. The discriminatory index (Hunter and Gaston, HGDI) for RFLP was 0.9937. Ninety-nine different MIRU-VNTR patterns were found, 95 of which had unique patterns and nine isolates were grouped into four clusters. The major allelic diversity index in the MIRU-VNTR loci ranged from 0.6568 to 0.7789. The global HGDI for MIRU-VNTR was 0.9991. Thirty-two different spoligotyping profiles were found: 16 unique patterns (n = 16) and 16 clustered profiles (n = 88). The HGDI for spoligotyping was 0.9009. The spoligotyped clinical isolates were phylogenetically classified into Latin-American Mediterranean (66.34 %), T (14.42 %), Haarlem (5.76 %), X (1.92 %), S (1.92 %) and U (unknown profile; 8.65 %). Among the U isolates, 77.8 % were classified further by 3R-SNP-typing as 44.5 % Haarlem and 33.3 % LAM, while the 22.2 % remaining were not classified. Among the 104 clinical isolates, 86 were identified by TB-SPRINT as MDR, 12 were resistant to rifampicin only, one was resistant to isoniazid only, three were susceptible to both drugs, and two were not successfully amplified by PCR. A total of 42, 28 and eight isolates had mutations in rpoB positions 531, 526 and 516, respectively. Correlating the cluster analysis with the patient data did not suggest recent transmission of MDR-TB.
CONCLUSIONS:
Although our results do not suggest strong transmission of MDR-TB in Minas Gerais (using a classical 100 % MDR-TB identical isolates cluster definition), use of a smoother cluster definition (>85 % similarity) does not allow us to fully eliminate this possibility; hence, around 20-30 % of the isolates we analyzed might be MDR-TB transmission cases.
Keywords in Portuguese
Epidemiologia molecularMinas Gerais
Mycobacterium tuberculosis
Resistência a medicamentos
Variação genética
Keywords
MDR-TBMolecular epidemiology
Spoligotyping
MIRU-VNTR
IS6110-RFLP
Minas Gerais, Brazil
Genetic diversity
Share